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Abstract
Background: Dedifferentiation of muscle cells in the tissue of mammals has yet to be observed. One of the challenges
facing the study of skeletal muscle cell dedifferentiation is the availability of a reliable model that can confidentially
distinguish differentiated cell populations of myotubes and non-fused mononuclear cells, including stem cells that can
coexist within the population of cells being studied.
Methodology/Principal Findings: In the current study, we created a Cre/Lox-b-galactosidase system, which can specifically
tag differentiated multinuclear myotubes and myotube-generated mononuclear cells based on the activation of the marker
gene, b-galactosidase. By using this system in an adult mouse model, we found that b-galactosidase positive mononuclear
cells were generated from b-galactosidase positive multinuclear myofibers upon muscle injury. We also demonstrated that
these mononuclear cells can develop into a variety of different muscle cell lineages, i.e., myoblasts, satellite cells, and muscle
derived stem cells.
Conclusions/Significance: These novel findings demonstrated, for the first time, that cellular dedifferentiation of skeletal
muscle cells actually occurs in mammalian skeletal muscle following traumatic injury in vivo.
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Introduction
The induction of multipotent or pluripotent stem cells from
differentiated cells, known as dedifferentiation, has been intensively
studied over the past number of years. Recently, a standard technique
for the generation of induced pluripotent stem (iPS) cells from adult
somatic cells has been established [1]; however, the cell sources for
these stem cell induction studies are typically from adult tissues where
adult stem cells are also known to exist [2,3,4]. Moreover, some
documentation suggests that adult stem cells in some tissues are
pluripotent [5,6,7]. Based on the heterogeneous nature of the various
cell sources utilized, it has been suggested that some of the cell
isolation techniques might not exclude all the stem cells from the
isolation, leaving the possibility that it is actually the contaminating
stem cells that are being induced and expanded in these studies rather
than the dedifferentiation of ‘‘terminally’’ differentiated somatic cells
[8]. From a cellular biology standpoint, it is very important to ensure
that the cells that are actually undergoing transformation during cell
dedifferentiation process are truly differentiated somatic cells and not
undifferentiated stem or progenitor cells which can coexist in the
tissue source [1,8]. Therefore, a model that could provide and ensure
that the cells utilized during the dedifferentiation procedure are
actually terminally differentiated somatic cells would be very
beneficial for these types of studies [8,9].
It is generally believed that the dedifferentiation process of
muscle cells occurs in injured skeletal muscle of some amphibians,
but is still questioned to occur in mammalian muscle. Skeletal
muscle is a good model for studying the process of dedifferenti-
ation due to its high regenerative capacity and the fact that the
terminally differentiated muscle cells are myofibers generated from
myogenic fusion [10,11]. In amphibian limb regeneration (i.e.,
newt and axolotl), it is the multipotent stem cells which are
generated via the dedifferentiation of myofibers that are the major
cell source for ‘‘blastema’’ formation and consequently ‘‘perfect’’
limb regeneration [11]. The multinuclear-to-mononuclear transi-
tion of muscle cells is a reversal of the myogenic fusion process and
is an important and necessary step of myogenic dedifferentiation.
Myogenic dedifferentiation in amphibians has been well docu-
mented, including the generation of stem cells from myofibers of
injured amphibian [11,12]. In mammalian systems, previous
studies on the induction of muscle cell dedifferentiation have been
claimed to be successfully conducted at two levels in vitro including:
the dedifferentiation of myotubes/myofibers into myocytes and
the dedifferentiation of myocytes into stem cell-like cells [13,14].
However, this phenomenon still remains controversial. For
example, in dedifferentiation studies involving myotubes, the
myotubes formed by myocyte fusion could have been contami-
nated with non-fused myocytes and in the experiments involving
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the isolation of myofibers, the myofibers could certainly have
possessed contaminating satellite cells or stem cells. Furthermore, a
similar problem exists with the studies involving the dedifferen-
tiation of myocytes into stem cells, due to the heterogeneous
nature of the isolated primary cells because it is impossible to
know, with absolution, that the cells were completely void of
undifferentiated cells (i.e., satellite cells or stem cells) [15].
Therefore, it is reasonable to suggest the use of a method to
specifically tag differentiated multinuclear myotubes and any
mononuclear myocytes released from the multinuclear myotubes
in order to confirm that the isolated cells are truly a credible source
of differentiated cells for the aforementioned stem-cell induction
studies.
The fusion of muscle cells to form multinuclear myofibers is
central to muscle development and has been historically thought to
be an irreversible process in mammals. Based on the cell-fusion
characteristics of muscle cells, we have created a Cre/Lox-b-
galactosidase (Cre-Lox) system [16] to specifically tag differenti-
ated multinuclear myofibers, as well as mononuclear cells released
from these tagged multinuclear myofibers via the in vivo
dedifferentiation of the skeletal muscle after injury. We also
isolated muscle cells from injured skeletal muscle tagged with the
Cre-Lox system to further characterize the mononuclear cells
generated and released from these myofibers in the injured muscle.
Results
Specificity of Cre-Lox system in tagging differentiated
myotubes in vitro
Muscle-derived cells (MDCs) from normal mice (C57BL6J, 4–6
weeks of age, male, Jackson Lab) were isolated and transfected
with a Cre-expressing retroviral vector to generate MDC-Cre.
The Cre gene (Cre, a DNA recombinase) is driven by a Muscle
Creatine Kinase (MCK) promoter that is active in differentiating
and differentiated muscle cells, such as activated myoblasts and
myotubes [17]. Another population of MDCs were isolated from
129-Gt(ROSA)26Sortm1Sho (Lox-b-gal) reporter mice (MDC-
Lox, 5–6 weeks of age, male, Jackson Lab). When MDC-Cre cells
were co-cultured with MDC-Lox cells, the possible fusion of the
two kinds of cells resulted in Cre recombinase-mediated cleavage
of Lox sites and the induction of b-gal/LacZ expression in the
fused/differentiated myotubes (Fig. 1A). To test the specificity of
this Cre-Lox system in vitro, MDC-Cre and MDC-Lox cells were
mixed (1:1) in differentiation medium to promote muscle cell
fusion. Homogeneous fusion of MDC-Lox cells were also studied
as a control group to exclude the possibility that the Lox-b-gal
reporter may express without Cre-mediated DNA recombination
(Fig. 1B). The result showed that the b-gal/LacZ signal was not
observed in the homogenous MDC-Lox cells, but was exclusively
observed in multinuclear myotubes in the co-culture of MDC-Cre
and MDC-Lox cells (Fig. 1B–E). This observation demonstrates
the specificity of our Cre-Lox system for tagging terminally
differentiated muscle cells. This finding also suggests that if any b-
gal/LacZ positive mononuclear cells exist in the culture, they must
have been generated and released from the differentiated b-gal/
LacZ positive multinuclear myotubes, and can therefore be
considered as dedifferentiated myocytes having an origin from
differentiated cells/tissue (Fig. 1F).
Transplantation of cells transfected with the Cre-Lox
system into mice and observation of b-gal/LacZ positive
cells in injured muscle
After creating the model and verifying its specificity in vitro, we
utilized the system in vivo to investigate whether mononuclear
myocytes could be generated from differentiated myofibers and
whether these dedifferentiated myocytes could then be further
dedifferentiated into SC-like cells in the injured muscle of mice.
Firstly, to verify the efficiency of the Cre-Lox system in vivo, equal
numbers of MDC-Cre and MDC-Lox cells (0.36106 cells each)
were mixed and implanted via intramuscular injection into the
gastrocnemius (GM) muscles of MDX/SCID mice, an immuno-
deficient, dystrophic mouse model, and allowed to completely
differentiate and fuse within the host muscle. Three weeks after
implantation, many b-gal/LacZ positive myofibers were observed
and no obvious b-gal/LacZ positive mononuclear cells were
detected at the cell implantation site (Fig. 2A&B), verifying that the
Cre-Lox system also functioned in vivo. In the next set of
experiments, we implanted the same MDC-Cre and MDC-Lox
cell mix that we utilized above into the non-injured muscle of
SCID mice. Three weeks after cell implantation, we observed
similar results that we had in the MDX/SCID mice (Fig. 2C&D);
however, when a laceration injury was created in the GMs of these
mice at the cell implantation site, mononuclear cells that were b-
gal/LacZ positive were detected four days after the creation of the
injury (Fig. 2E–G, arrowheads). Moreover, a sub-population of the
b-gal/LacZ positive mononuclear cells that was also positive for
Pax7 was observed in the injured muscles (Fig. 2H–K, arrow-
heads). Pax7 is a cell marker of satellite cells that is no longer
expressed when the cells are committed to differentiate or have
already differentiated. These latter results also suggest that the
population of b-gal/LacZ positive mononuclear cells may be
heterogeneous and contain different subpopulations. These results
demonstrated that differentiated myofibers (b-gal/LacZ positive
fibers) could dedifferentiate into Pax-7 expressing precursor cells
after myofiber injury, which indicates that dedifferentiation may
play a role in the healing process of mammalian skeletal muscle.
b-gal/LacZ positive mononuclear cells are present in
different cell populations from the preplate isolated
muscle cells
In order to further confirm the generation of dedifferentiated b-
gal/LacZ positive mononuclear cells in the injured muscle, and in
order to find out what cell populations contain these b-gal/LacZ
positive cells, we isolated muscle cells from the injured and non-
injured skeletal muscles of SCID mice that contained b-gal/LacZ
positive multinuclear myofibers and mononuclear cells 4 days after
muscle injury. With flow cytometry, we analyzed the population
for its percentage of b-gal/LacZ positive mononuclear cells among
the total number of isolated mononuclear cells. Different
populations of cells can be separated using the pre-plate technique
which separates cells based on their different affinities for adhering
to collagen-coated flasks [18,19]. For example, myoblasts adhere
early on, usually after the 2nd or 3rd preplate (i.e. PP2 or PP3)
passage, satellite cells adhere at approximately PP5, and muscle
derived stem cells adhere at PP6. The cells isolated from the
injured skeletal muscles of SCID mice showed that b-gal/LacZ
positive mononuclear cells exist in both populations of myoblasts
(Fig. 3A–C) and satellite cells (Fig. 3D–F), as well as in the Muscle
Derived Stem Cell (MDSC) population (Fig. 3G–H), indicating
that b-gal/LacZ positive myocytes should be able to take part in
the re-construction of injured muscle. More importantly, many
more b-gal/LacZ positive cells expressing the SC markers Sca-1
and CD34 [18] were observed in the population of cells isolated
from injured muscle, compared to normal non-injured muscle
(Fig. 3I–K). These results verify the existence of different
populations of b-gal/LacZ positive mononuclear cells in the
healing process, and suggest that dedifferentiation can be induced
via muscle injury and that muscle progenitor cells (i.e., satellite
Dedifferentiation of Skeletal Muscle Cells
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cells and MDSCs) can be generated through the process of
dedifferentiation. This observation suggests that the increased
population of stem cells present in injured muscle tissue is
comprised of not only satellite cells, stem cells, and circulating
blood cells, but also by cells that are being generated through the
process of dedifferentiation from ‘‘terminally’’ differentiated
myofibers.
b-gal/LacZ positive mononuclear cells can proliferate,
and contribute to myotube formation in vitro, as well as
contribute to re-vascularization in injured skeletal muscle
in vivo
We continued to investigate whether the b-gal/LacZ positive
mononuclear cells isolated via the preplate technique from the
injured muscle of SCID mice injected with the Cre-Lox cells had
the same proliferation and myogenic differentiation capacities
typically observed by muscle progenitor cells. BrdU incorporation
studies showed that b-gal/LacZ positive mononuclear cells could
enter the S-phase of the cell cycle, indicating that the proliferation
capacity of the cells is positive (Fig. 4A–C). The in vitro myogenic
studies showed that b-gal/LacZ positive mononuclear cells (non-
purified PP6 cells or purified b-gal/LacZ positive cells from PP6)
were able to participate in myotube formation, although the
purified b-gal/LacZ positive cells showed a slower myogenic
differentiation process (Fig. 4E–F). Also, we noticed that the in vivo
implantation of the Cre-Lox cell mix into the skeletal muscle of
SCID mice resulted in the appearance of b-gal positive signal in
both the myofibers and CD31 positive blood vasculature 10 days
after muscle injury (Fig. 4G–L). This finding indicates that the b-
gal/LacZ positive mononuclear cells released from myofibers after
injury could differentiate into endothelial cells and participate in
the re-vascularization of the tissue.
Discussion
In this study, we have utilized a Cre/Lox-b-galactosidase (Cre-
Lox) system [16,20] to specifically tag multinuclear myofibers as well
as any mononuclear cells released from the tagged myofibers via
dedifferentiation in vitro and in vivo. Utilizing this Cre-Lox model, we
not only created a system to identify truly differentiated muscle cells
which will be available for further cell dedifferentiation studies, but
Figure 1. Specificity of the Cre-Lox system in differentiated myotubes in vitro. Schematic representation of the Cre/Lox-b-galactosidase
system used in the current study (A). (b-gal/LacZ)+ cells were not observed with homogenous fusion of MDC-Lox cells (B). In co-cultured MDC-Cre
and MDC-Lox cells, (b-gal/LacZ)+ cells can be either nascent myotubes with 2 nuclei (C, nuclei marked by arrows; 2 days after myogenic
differentiation), or mature myotubes with multiple nuclei (D, nuclei marked by arrows; 4 days after myogenic differentiation). No (b-gal/LacZ)+
mononuclear cells were observed. Statistical quantification of (b-gal/LacZ)+ myotubes is shown (E). It is proposed that the presence of any
mononuclear cells positive for b-gal expression in the culture have to be released from (b-gal/LacZ)+ myotubes, that is, after some type of
stimulation, myotubes formed through the fusion of MDC-Cre and MDC-Lox cells, dedifferentiate and release the mononuclear (b-gal/LacZ)+ cells (F).
doi:10.1371/journal.pone.0016699.g001
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were also able to demonstrate that dedifferentiation does occur in
mammalian skeletal muscle following injury. We were able to show
two tiers to the dedifferentiation including the dedifferentiation of
myofibers to myocytes and the dedifferentiation of myocytes to even
earlier progenitor cells including muscle-derived stem cells (CD34/
Sca1 expressing cells).We also showed that these dedifferentiated cells
were able to proliferate and undergo myogenic differentiation the
same as any other muscle progenitor cell could do. In addition, the
dedifferentiated cells were capable of differentiating into non-muscle
cell related cell lineages (i.e., endothelial cells involved in revascular-
ization of the injured tissue). Our results suggest that, in addition to
resident stem cells and circulating stem cells, dedifferentiated muscle
cells also appear to be a source of muscle progenitor cells contributing
to the muscle healing process.
A variety of Cre-Lox models have been used in such a manner
as to be explicitly activated in specific tissue types or cell types or
only when the expression of certain gene(s) are modified in order
to trace cell lineages [21,22]. A Cre/Lox-b-galactosidase system,
similar to ours, had been used to detect cell fusion events of bone-
marrow-derived cells (BMDCs), neurons, and cardiomyocytes
[23]. The Cre-Lox system was proven effective for specifically
tagging differentiated myofibers to study the process of trans-
differentiation in the development and tail regeneration of
Xenopus, a genus of aquatic frogs [24]. In this novel study we
used the Cre-Lox system to study the process of dedifferentiation
in mammalian skeletal muscle. The results generated from these
studies indicated that the Cre-Lox system can serve as an efficient
tool for the study of muscle cell dedifferentiation and can be used
Figure 2. Cre/Lox-b-galactosidase cell transplantation and muscle injury resulted in b-gal/LacZ positive mononuclear cells. Three
weeks after cell transplantation into MDX/SCID mice, many (b-gal/LacZ)+/dystrophin+ myofibers were observed (A, B). b-gal/LacZ staining and
immunofluorescent Pax7/dystrophin staining are shown here; arrows indicate (b-gal/LacZ)+/dystrophin+ myofibers which are the result of the fusion
of Cre-Lox myocytes, and arrowheads indicate (b-gal/LacZ)2/dystrophin2 host myofiber (A, B). Three weeks after transplantation and four days after
muscle injury in SCID mice, some (b-gal/LacZ)+ mononuclear cells were observed in the injured muscle (E–G), but not in the control non-injured
muscle (C, D). Results of b-gal/LacZ staining and HE staining are shown here; arrows indicate (b-gal/LacZ)+ myofibers, and arrowheads indicate (b-
gal/LacZ)+ mononuclear cells (C–G). Some of the (b-gal/LacZ)+ mononuclear cells were shown to be Pax7+ (H–K). Images H–J are of the same
location, and result of b-gal/LacZ staining and immunofluorescent Pax7/dystrophin staining are shown here (H–J); arrows indicate b-gal+/Pax7+
mononuclear cells, and arrowheads indicate b-gal+ myofibers (H–J). Fluorescent co-staining of b-gal and Pax7 are also shown (K); arrowheads
indicate b-gal+/Pax7+ mononuclear cells, and arrows indicate Pax7+ cells. Statistical quantification of the results is also shown (L).
doi:10.1371/journal.pone.0016699.g002
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to ensure that the somatic cells targeted in stem cell induction
studies are truly terminally differentiated.
Potential problems with the Cre-Lox system when performing
the dedifferentiation-differentiation studies may include the
potential for spontaneous fusion of the Cre and Lox cells to form
tetraploid hybrids without actually undergoing myogenic differ-
entiation [25,26], as well as the potential secretion and lateral
transfer of the Cre protein from the Cre-cells to the Lox-cells [27].
Figure 4. b-gal/LacZ positive cells can proliferate and contribute to myotube formation in vitro, and blood vessel formation in vivo.
BrdU incorporation assay showed that (b-gal/LacZ)+ cells can proliferate (A–C). A myogenic differentiation assay, which deprives the cultures of
serum, showed that (b-gal/LacZ)+ cells, in both cell populations without purification [ around 6% of cells were (b-gal/LacZ)+] (D) and after purification
with Fluorescence-activated cell sorting (E), can participate in myotube formation (F). In vivo, ten days after laceration-injury of GM muscles that were
transplanted with Cre-cells and Lox-cells for 3 weeks, some (b-gal/LacZ)+ signal was also found to co-localize with CD31+ signal in the blood
vasculature (G–L). Images G–I or J–L are of the same location in tissue, and result of b-gal/LacZ staining and immunofluorescent CD31/Utrophin
staining are shown here (G–I); arrowheads indicate b-gal+/CD31+ cells, and arrows indicate b-gal+ myofibers (G–I). Fluorescent co-staining of b-gal
and Pax7 are also shown (J–L); arrowheads indicate b-gal+/Pax7+ cells, and arrows indicate CD31+ cells (J–L).
doi:10.1371/journal.pone.0016699.g004
Figure 3. b-gal/LacZ positive mononuclear cells from injured muscle contain different cell populations (i.e., myoblasts, satellite
cells, and MDSCs). The result of flow cytometry analysis, b-gal/LacZ staining and immune-staining to MyoD or Pax7 showed that, the isolated PP2
(myoblasts) (A–C) and PP5 (satellite cells) (D–F) cell populations both contain (b-gal/LacZ)+ cells, which can be MyoD+ or Pax7+. The result of b-gal/
LacZ staining and immune-staining to Sca-1 also showed that, the PP6 cells (MDSCs) also contain (b-gal/LacZ)+ cells, which were shown to be Sca-1+
(G, H). Flow cytometry analysis comparing PP6 cells from non-injured control muscles and the PP6 cells from injured muscle demonstrated a greater
number of (b-gal/LacZ)+ cells which also expressed Sca-1 and CD34 in the injured muscle (I–J), indicating that adult stem cells can be dedifferentiated
from ‘‘terminally’’ differentiated muscle fibers in injured skeletal muscle of mice. Statistical quantification of the flow cytometry results is shown (K).
doi:10.1371/journal.pone.0016699.g003
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In both of these two hypothetical situations, b-gal expression could
occur in non-differentiated mononuclear cells; however, the
spontaneous fusion of skeletal muscle myoblasts to form tetraploid
hybrids has never been documented. Moreover, the Cre gene in
our system is driven by an MCK promoter which is only active in
differentiating and mature differentiated muscle cells [17], which
minimizes the possibility of Cre expression in non-differentiated
mononuclear cells. Furthermore, in our experiments, no b-gal
positive mononuclear cells or non-differentiated cells were
observed during the in vitro co-culture and myogenic differentiation
of the Cre-cells and Lox-cells. This observation suggests that the
possibility of spontaneous fusion or lateral transfer of the Cre
protein, if any, would be limited, and would not contribute
significantly to the generation of b-gal positive mononuclear cells.
In fact, a small number of b-gal/LacZ positive mononuclear cells
was also observed in non-injured normal muscle implanted with
Cre-Lox cells in our study, which could be related with the minor
injuries in the normal muscle induced by strenuous exercise or
unaccustomed movement of the animals [28].
In conclusion, we have created a Cre-Lox model to study the
process of myogenic dedifferentiation and a method to obtain
confirmed ‘‘terminally’’ differentiated myogenic cells for use in
dedifferentiation studies. In addition, this research led to the
confirmation for the first time that dedifferentiation does indeed
occur in the injured skeletal muscle of mice, and that the
dedifferentiation of ‘‘terminally’’ differentiated cells may constitute
an additional cell source to aid in the healing process of injured
skeletal muscle. Our results provide a greater understanding of the
skeletal muscle healing process after injury or from disease, and
will shed light on the role of cellular dedifferentiation in
regenerative medicine. Additional studies are needed to confirm
this similar phenomenon in other mammalian species.
Materials and Methods
Cre-Lox system
The use of animals and the surgical procedures performed in
this study were approved by the Institutional Animal Care and
Use Committee (IACUC) of University of Pittsburgh Medical
Center (Protocol 0904641). Muscle-derived cells (MDCs) were
isolated from normal mice (C57BL/6J, 4–6 weeks of age, male,
Jackson Laboratory) and transfected with a Cre-expressing
retroviral vector to make MDC-Cre. The Cre-retroviral vector
was built with a pCLXSN retroviral expression vector (Addgene)
which is under the control of the MCK promoter and also carries
a neomycin-resistance gene (Fig. 1A). MDCs transfected with the
Cre-retroviral vector were selected with G418 (1 mg/mL) for 2
passages over a 5 day period to obtain a purified Cre-expressing
cell population. MDC-Lox were isolated from Lox-b-gal reporter
mice (B6;129-Gt(ROSA)26Sortm1Sho/J, 5–6weeks of age, male,
Jackson laboratory), in which expression of the b-gal reporter gene
is silenced by a LoxP-flanked stop codon. Fusion of MDC-Cre and
MDC-Lox cells resulted in Cre-mediated cleavage of the Lox sites
and the induction of b-galactosidase (b-gal) expression, which is
regulated with a CMV promoter. This Cre-Lox system effectively
tags differentiated myotubes and myofibers and enables us to track
their fate both in vitro and in vivo.
Cell transplantation of MDCs to the skeletal muscle of
mice
All experimental animal protocols were approved by the Animal
Research and Care Committee in the Children’s Hospital of
Pittsburgh of UPMC. The mice utilized in these studies were
either SCID mice (C57BL/6J-Prkdcscid/SzJ, female, 4-week old,
Jackson Laboratory) or MDX/SCID mice (bred in the institution’s
animal facility by crossing C57BL/10ScSn-Dmdmdx, male, Jackson
Laboratory, and C57BL/6J-Prkdcscid/SzJ mice, female, 4-week old,
Jackson Laboratory). For all experiments involving cell transplan-
tation with the Cre/Lox system, equal numbers of MDC-Cre and
MDC-Lox (0.36106 cells each) were mixed and transplanted into
the gastrocnemius (GM) muscles in both legs of mice for up to 3
weeks, allowing for fusion of the transplanted cells into myofibers
before creating the laceration muscle injury.
Skeletal muscle injury
GM muscles of mice that had been transplanted with MDC-
Cre/MDC-Lox 3 weeks earlier were then injured via a laceration
at the site of the implanted cells. Lacerations were performed on
the GM muscle of one leg of each mouse through 50% of its width
and 100% of its thickness at 60% of its length, which covered the
location of the implanted cells. The GM muscle of the other leg
served as a non-injured control.
Isolation of skeletal muscle cells
Four days after muscle laceration injury the mice were
sacrificed, and the skeletal muscle cells were isolated from the
GM muscle of the mice. Using a modified preplate technique
[18,19], different populations of muscle cells were isolated and
cultured on collagen-coated flasks. The harvested GM muscle was
cut and minced into a coarse slurry. The muscle slurry was then
digested by serial 1-hr incubations at 37uC in 0.2% type XI
collagenase (Sigma), dispase (grade II, 240 units; Sigma), and 0.1%
trypsin (GIBCO-BRL). The cell suspension was then passed
through 22-gauge needles, centrifuged at 3000 rpm for 5 min, and
resuspended in growth medium (Dulbecco’s modified Eagle’s
medium supplemented with 10% Fetal Bovine Serum (FBS), 10%
Horse Serum (HS), 1% Penicillin-Streptomycin antibiotics, and
0.5% chicken embryo extract (CEE)]; all from GIBCOBRL). After
the cells were plated in collagen-coated flasks as indicated by the
pre-plate technique, the fast adhering cells (i.e., PP1 and PP2) were
then cultured with growth medium for myoblasts as outlined
above, and the slow adhering cells (i.e., PP5 and PP6) continued to
be cultured in growth medium to isolate and expand the stem cells
(The same component as medium for myoblasts except with 20%
FBS), and incubated in 5% CO2 at 37uC.
b-gal/LacZ staining and immunofluorescent staining of
cells and tissue sections
GM muscle tissues from SCID or MDX/SCID mice were
harvested and snap frozen in liquid nitrogen-cooled 2-methylbu-
tane and cryo-sectioned at 10mm. Cultured cells were fixed with
4% paraformaldehyde and tissue cryo-sections were fixed with 4%
formalin. For b-gal/LacZ staining, fixed cells/sections were
incubated in 5-bromo-4-chloro-3-indolyl-b-D-galactoside (X-gal)
solution at 37uC for 24 hours. For immunofluorescent staining,
10% HS was used to block nonspecific background for 1 hour.
The primary antibodies, Pax7 (DHSB), Dystrophin (Abcam),
MyoD (Santa Cruz), CD34 (BD Biosciences), Sca-1 (BD
Biosciences) were applied at 1:100,200. After incubating with
fluorescent secondary antibodies, fluorescence microscopy (Leica
Microsystemic Inc., IL) was used to visualize all of the
immunofluorescence results and capture photographic images.
Flow cytometry study of isolated muscle stem cells
PP6 cell populations from our MDX/SCID mice or SCID mice
were characterized by flow cytometry for CD34 and Sca-1
expression. PP6 cells were labeled with biotin-conjugated anti–
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mouse Sca-1 and CD34 Abs (BD Biosciences). A separate portion
of cells was treated with equivalent amounts of isotype control
antibodies. Both fractions were washed and labeled with
fluorescent-tagged streptavidin-allophycocyanin. Sca-1 and
CD34 expression was determined by flow cytometry with a cell
sorter (FACStar Plus or FACSAria; Becton Dickinson).
Bromodeoxyuridine (BrdU) incorporation assay
Muscle cells were isolated from the injured muscle of our SCID
mice and cultured with BrdU (BD Bioscience) (1:1000) in
proliferation medium for 16 hrs, as described previously [29].
The cells were then fixed with 4% paraformaldehyde and
immunostained with an antibody against BrdU (Abcam). b-gal/
LacZ staining was then performed and the presence of cells
colocalized with BrdU (cells which are undergoing proliferation)
and b-gal/LacZ (dedifferentiated cells) were determined. The
percentages of BrdU positive mononuclear cells in the populations
of b-gal/LacZ positive and b-gal/LacZ negative mononuclear
cells were then quantified.
Flow cytometric cell sorting of b-gal positive cells
Around 26104 muscle cells isolated from the injured muscles of
our SCID mice were immunostained with an antibody against b-
gal (sigma), and b-gal positive cells was determined and isolated by
flow cytometry with a cell sorter (FACStar Plus or FACSAria;
Becton Dickinson).The sorted cells were then immediately
cultured in the proliferation medium.
In vitro myogenic differentiation assay of b-gal/LacZ
positive cells
A myogenic differentiation assay was conducted on both non-
purified PP6 cells containing b-gal/LacZ positive cells and b-gal/
LacZ positive cells purified from the PP6 cells by flow cytometric
cell sorting, as described previously [30]. Briefly, cells were
cultured in proliferation medium (PM) (DMEM supplemented
with 10% HS, 10% FBS and 1% P/S) to 85% confluence. PM was
then changed to myogenic differentiation medium (DMEM
supplemented with 2% HS and 1% P/S), and incubated in 5%
CO2 at 37uC for 4 days. Myotube formation was then quantitated.
Statistical analysis
The in vitro and in vivo measurement and quantification of the
mononuclear cells positive for BrdU or b-gal/LacZ and
myotubes/myofibers positive for b-gal/LacZ was conducted using
Northern Eclipse software (version 6.0, Empix Imaging Inc.,
Mississauga, ON, Canada). At least 3 identically treated cell
cultures or tissue sections from 4 identically treated mice for each
group were used to generate the data, which was analyzed based
on 3 pictures of each cell culture or tissue section. All of the results
from these studies are expressed as the mean 6 standard deviation
(SD). The differences between means were considered statistically
significant if P value was ,0.05. The ANOVA test was used to
compare the differences between different groups of cells or tissue
sections.
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